Article Text
Abstract
Aims To establish expert recommendations for the management of ocular sarcoidosis (OS).
Methods A question-based survey on the management of OS was circulated to international uveitis experts (members of the International Uveitis Study Group and the International Ocular Inflammation Society) electronically. Subsequently, a consensus workshop was conducted at the 7th International Workshop on Ocular Sarcoidosis (IWOS) in June 2019 in Sapporo, Japan as part of the Global Ocular Inflammation Workshops. Statements on the management of OS that were supported by a two-thirds majority of 10 international panel members of the workshop, after discussion and voting, were taken as consensus agreement.
Results A total of 98 participants from 29 countries responded to the questionnaire survey. The subsequent consensus workshop established recommendations for the management of OS in five sections. The first section concerned evaluation and monitoring of inflammation. The second, third and fourth sections described ocular manifestations that were indications for treatment, and the management of anterior uveitis, intermediate uveitis and posterior uveitis. In the fifth section, the use of systemic corticosteroids and systemic immunosuppressive drugs were detailed.
Conclusions Recommendations for management of OS were formulated through an IWOS consensus workshop.
- Treatment Medical
- Inflammation
- Drugs
- Diagnostic tests/Investigation
Statistics from Altmetric.com
Footnotes
7th IWOS Study Group: See online supplementary appendix 1.
MM and JRS contributed equally to this work and share senior authorship of this manuscript.
Correction notice This paper has been corrected since it was published online. During the production process the production team failed to include 7th IWOS Study Group in the author list. We would like to apologise for this error.
Contributors MM and JRS conceived the project; designed the study; collected the questionnaire survey; designed, conducted and moderated the seventh International Workshop on Ocular Sarcoidosis on June 29, 2019 in Sapporo, Japan. HT, MM and JRS drafted the manuscript. NRA, KB, BB, MK, PJM, NT, JET, ITT, JHY and NAR reviewed and edited the manuscript draft. HT analysed the results of the questionnaire survey. MM, JRS and HT built up questionnaire survey, designed the study and reviewed the questionnaire survey. NAR made suggestions for the study. All authors and members of International Workshop on Ocular Sarcoidosis Study Group participated in the questionnaire survey and in the seventh International Workshop on Ocular Sarcoidosis on June 29, 2019 in Sapporo, Japan. All authors approved submission.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement All data relevant to the study are included in the article or uploaded as online supplemental information.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
Linked Articles
- At a glance